Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Kram

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioengineering (Basel, Switzerland)|September 26, 2018
Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted TherapeuticsDavid E Kram, Jacob J Henderson, Muhammad Baig, et al.
Plos One|December 21, 2016
Dexamethasone Chemotherapy Does Not Disrupt Orexin SignalingDavid E Kram, Stephanie M Krasnow, Peter R Levasseur, et al.
Research Square|September 18, 2025
Automated Computer Vision and Dose-Response Modeling Improve Throughput and Accuracy of an <i>Ex Vivo</i> Functional Precision Medicine PlatformNoah Bell, Andrew Buckley, Breanna Mann, et al.
Scientific Reports|December 16, 2025
Automated computer vision and dose-response modeling improve throughput and accuracy of an ex vivo functional precision medicine platformNoah Bell, Andrew Buckley, Breanna Mann, et al.
Scientific Reports|April 21, 2026
Correction: Automated computer vision and dose-response modeling improve throughput and accuracy of an ex vivo functional precision medicine platformNoah Bell, Andrew Buckley, Breanna Mann, et al.
Molecular Cancer Therapeutics|March 25, 2025
Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient GlioblastomaHumeyra Kaanoglu, Adebimpe Adefolaju, Casey Fraley, et al.
Plos One|March 5, 2026
An ex vivo functional biomarker of treatment response in pediatric low-grade gliomaNichole M Artz, Breanna Mann, Aaron Ebbs, et al.
JCO Precision Oncology|March 2, 2022
Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC StudyJacob J Henderson, Anirban Das, Daniel A Morgenstern, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioengineering (Basel, Switzerland)|September 26, 2018
Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted TherapeuticsDavid E Kram, Jacob J Henderson, Muhammad Baig, et al.
Plos One|December 21, 2016
Dexamethasone Chemotherapy Does Not Disrupt Orexin SignalingDavid E Kram, Stephanie M Krasnow, Peter R Levasseur, et al.
Research Square|September 18, 2025
Automated Computer Vision and Dose-Response Modeling Improve Throughput and Accuracy of an <i>Ex Vivo</i> Functional Precision Medicine PlatformNoah Bell, Andrew Buckley, Breanna Mann, et al.
Scientific Reports|December 16, 2025
Automated computer vision and dose-response modeling improve throughput and accuracy of an ex vivo functional precision medicine platformNoah Bell, Andrew Buckley, Breanna Mann, et al.
Scientific Reports|April 21, 2026
Correction: Automated computer vision and dose-response modeling improve throughput and accuracy of an ex vivo functional precision medicine platformNoah Bell, Andrew Buckley, Breanna Mann, et al.
Molecular Cancer Therapeutics|March 25, 2025
Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient GlioblastomaHumeyra Kaanoglu, Adebimpe Adefolaju, Casey Fraley, et al.
Plos One|March 5, 2026
An ex vivo functional biomarker of treatment response in pediatric low-grade gliomaNichole M Artz, Breanna Mann, Aaron Ebbs, et al.
JCO Precision Oncology|March 2, 2022
Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC StudyJacob J Henderson, Anirban Das, Daniel A Morgenstern, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 3